Salt Intake, Hydration Status and Gastrointestinal Discomfort During Fasting

NCT ID: NCT05839860

Last Updated: 2023-09-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

23 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-02-14

Study Completion Date

2023-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is part of a hyperhydration project and it has been designed based on a scoping review (Hyperhydration in healthy adults: a scoping review on different methodologies and vehicles utilized) and a previous study (Dietary patterns and gastrointestinal discomfort during Ramadan in a UK Muslim population). The current study aims to examine the impact of different levels of salt intake (6 \& 9 grams) with \[15 milliliters per kilogram of bodyweight (ml/ kg/ bw)\] of water intake during 7 hours of dry fasting compared to a control group (3g salt) under the state of water balance (euhydrated). A previous study and a review by the authors highlighted the potential negative impact of salt and fasting on gastrointestinal (GI) discomfort; hence, the potential negative side effects on gastrointestinal (GI) discomfort during the intervention period will be investigated. By studying a hyperhydration protocol, this research will help the population to reduce dehydration during dry fasting. By doing so, it may improve the quality of life during Ramadan fasting.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Dry fasting has been reported to cause changes in body weight, lipid profile, blood pressure, glucose level, metabolism, hormones homeostasis, and hydration status. A scoping review by the investigators highlighted that dehydration had been linked to changes in plasma volume and osmolality (concentration of all chemical particles), urine volume and osmolality, blood pressure, glucocorticoid hormones, body weight loss, negative impact on mood, irritability, short-term memory, and work productivity. It has been reported that prolonged dry fasting can contribute to a loss of up to 1.5 kg in body weight on the day after fasting. This weight loss is associated with loss of body water.

Hyperhydration (overhydration) has not yet been defined. However, any improvement in the fluid matrix in the plasma volume is considered hyperhydration. Simulating hyperhydration strategies, such as those used by athletes competing in long-distance events and in hot environments, has the potential to reduce the level of dehydration during dry fasting.

Sodium and water intake have essential roles in maintaining and improving the fluid matrix in plasma. By investigating the relationship between sodium and water intake on biomarkers such as urine sodium concentration, blood pressure, speed of urine production, urine colour, urine specific gravity, and net body fluid balance, it is possible to distinguish the impact of hyperhydration protocols on hydration levels.

The primary aim of this study is to examine the impact of salt intake (6 \& 9 g/l) on the level of hydration by measuring urine sodium, urine potassium, urine production, and changes in body weight compared to the control group during 8 hours of dry fasting. The secondary outcome of this study will be the impact of the hyperhydration protocol on GI discomfort.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

3 g salt

Tomatoes with 3 g salt

Group Type PLACEBO_COMPARATOR

Salt 3 g

Intervention Type OTHER

Placebo group taking a breakfast meal and 3g salt on tomatoes before fasting for 7 hours

6 g salt

Tomatoes with 6 g salt and 1 L of water

Group Type EXPERIMENTAL

Salt 6 g

Intervention Type OTHER

Intervention group taking a breakfast meal and 6g salt on tomatoes plus 1 L water before fasting for 7 hours

9 g salt

Tomatoes with 9 g salt and 1 L of water

Group Type EXPERIMENTAL

Salt 9 g

Intervention Type OTHER

Intervention group taking a breakfast meal and 9g salt on tomatoes plus 1 L water before fasting for 7 hours

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Salt 3 g

Placebo group taking a breakfast meal and 3g salt on tomatoes before fasting for 7 hours

Intervention Type OTHER

Salt 6 g

Intervention group taking a breakfast meal and 6g salt on tomatoes plus 1 L water before fasting for 7 hours

Intervention Type OTHER

Salt 9 g

Intervention group taking a breakfast meal and 9g salt on tomatoes plus 1 L water before fasting for 7 hours

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Aged 18 to 45
* BMI between 18.5 and 29.9
* No higher (140/90mmHg) or lower (80/60mmHg) blood pressure
* Non-pregnant or lactating
* No diabetes (type 1 \& 2)
* No gastrointestinal disease such as inflammatory bowel disease (IBD) or Irritable bowel syndrome (IBS)
* No disease including the common cold and high cholesterol (total cholesterol above 5 mmol/l)
* No covid symptoms
* No allergy to the food in the meal list and tomatoes

Exclusion Criteria

* Aged \<18 or \>45 years
* BMI between \<18.5 or \> 29.9
* Higher (\>140/90mmHg) or lower (\<80/60mmHg) blood pressure
* Pregnant or lactating
* Having diabetes (type 1 \& 2)
* Having gastrointestinal disease such as inflammatory bowel disease (IBD) or Irritable bowel syndrome (IBS)
* Having disease including the common cold and high cholesterol (total cholesterol above 5 mmol/l)
* Having covid symptoms
* Having allergy to the food in the meal list and tomatoes
Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Oxford Brookes University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Dr. Sangeetha Thondre

Senior Lecturer

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Sangeetha Thondre, PhD

Role: PRINCIPAL_INVESTIGATOR

Oxford Brookes University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Oxford Brookes Centre for Nutrition and Health

Oxford, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

References

Explore related publications, articles, or registry entries linked to this study.

Goulet EDB, De La Flore A, Savoie FA, Gosselin J. Salt + Glycerol-Induced Hyperhydration Enhances Fluid Retention More Than Salt- or Glycerol-Induced Hyperhydration. Int J Sport Nutr Exerc Metab. 2018 May 1;28(3):246-252. doi: 10.1123/ijsnem.2017-0310. Epub 2018 May 17.

Reference Type BACKGROUND
PMID: 29140136 (View on PubMed)

Zanetti D, Bergman H, Burgess S, Assimes TL, Bhalla V, Ingelsson E. Urinary Albumin, Sodium, and Potassium and Cardiovascular Outcomes in the UK Biobank: Observational and Mendelian Randomization Analyses. Hypertension. 2020 Mar;75(3):714-722. doi: 10.1161/HYPERTENSIONAHA.119.14028. Epub 2020 Feb 3.

Reference Type BACKGROUND
PMID: 32008434 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

UREC 221630

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Kids Rehydration During Exercise
NCT05989607 COMPLETED NA
Carbohydrate Ingestion Prior to Surgery (CIPS)
NCT06057532 ACTIVE_NOT_RECRUITING NA
Metabolic Effects of Non-Nutritive Sweeteners
NCT01200940 COMPLETED PHASE1/PHASE2